ELISA Kit for Breast Cancer Anti-Estrogen Resistance 3 (BCAR3)

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

78.12-5000pg/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Homo sapiens (Human)

Sensitivity

The minimum detectable dose of this kit is typically less than 27pg/mL

Sample type

Serum, plasma, tissue homogenates and other biological fluids.

Assay length

3h

Method

Double-antibody Sandwich

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Breast Cancer Anti-Estrogen Resistance 3 (BCAR3). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Breast Cancer Anti-Estrogen Resistance 3 (BCAR3). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Breast Cancer Anti-Estrogen Resistance 3 (BCAR3), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Alternative Names

NSP2; SH2D3B; Novel SH2-containing protein 2; SH2 domain-containing protein 3B

Item Name

Breast Cancer Anti-Estrogen Resistance 3

Research Area

Tumor immunity;

Reference